Name: Biome Australia (BIO) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

BIO

Biome Australia

Household & Personal Products

Biome Australia focuses on the licensing, development, and marketing of complementary medicines, including nutraceuticals and live biotherapeutics. The company operates within the household and personal products industry, aiming to provide innovative health solutions. Biome Australia distributes their products through pharmacies and health food stores.

Short position

short percentage0.00%

reported shorts898

shares on issue227.998M

Biome Australia (ASX:BIO) has 0.00% of its shares on issue reported as short positions as of 20 Aug 2026, or about 898 shares. Over the past 30 days that figure has fallen 0.07 percentage points, and over 90 days it has fallen 0.18 percentage points. Its highest recorded short interest was 0.26% in January 2025. BIO is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Weekly context: The 10 most shorted ASX stocks — Week 39, 2026.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

BIO intelligence dossier

Public-source evidence for this company, with industry drill-up links.

Tax paid and taxable income records
Government contracts and public money
Emissions and trade exposure
Political donations and lobbying links

Short interest history & FAQ

BIO Short Interest History

30-day change: -0.07pp
90-day change: -0.18pp
1-year change: -0.14pp
All-time high: 0.26% (January 2025)
All-time low: 0.00% (August 2024)

Is BIO heavily shorted?

Not especially: 0.00% short interest is modest by ASX standards. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has BIO's short interest changed recently?

Over the past 30 days Biome Australia's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.00% of shares on issue.

What is the highest BIO's short interest has been?

Since 2023, Biome Australia's short interest peaked at 0.26% in January 2025 and bottomed at 0.00% in August 2024.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2023. See our methodology.

BIO fundamentals

In the 12 months to 30 Jun 2026, Biome Australia (ASX:BIO) recorded revenue of A$23.9M and net profit after tax of A$3.6M. Year-on-year growth: revenue +79.8% (FY). Net margin 15.1% (TTM). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 28 Sep 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Strategy fit

How each stock picker strategy reads BIO today

PassFailUnknown (data missing, or not meaningful for this company)

Zanger Breakout
WatchScore 35rank 103 of 1833
- 1. Explosive growth: pass. Revenue +79.8% YoY (FY ending 2024-06-30), accelerating from +75.9%; EPS +1490.0% YoY (12 months to 2026-06-30)
- 2. A recognisable base: fail. No tight base: only 7 sessions since the pivot high was first set, under 20; 41.6% deep, deeper than 25%
- 3. Breakout on heavy volume: fail. No close above the A$0.45 pivot on 1.5x volume in the last 5 sessions; close is -9.0% from the pivot
- 4. Read the market first: fail. XJO in a downtrend: below its 200-day average
- 5. Relative strength: pass. Beat the S&P/ASX 200 by 66.3 points over 3 months
- 6. Liquid enough to trade: fail. A$83k average daily turnover over 20 sessions, below the A$250k floor
CAN SLIM
WatchScore 50rank 5 of 1234
- 1. Earnings growth (C and A): pass. EPS +1490.0% YoY (12 months to 2026-06-30)
- 2. Sales growth: pass. Revenue +79.8% YoY (FY ending 2024-06-30), accelerating from +75.9%
- 3. New highs (N): fail. 17.3% below the 52-week high, more than 5% away
- 4. Leader, not laggard (L): pass. 6-month relative strength +24.6 points, in the top quartile (cut-off +7.8)
- 5. Market direction (M): fail. XJO in a downtrend: below its 200-day average
- 6. Supply and demand (S): fail. A$83k average daily turnover over 20 sessions, below the A$250k floor
Minervini Trend Template
WatchScore 41rank 442 of 1768
- 1. Above rising averages: fail. Close A$0.41, 150-day A$0.31, 200-day A$0.34: 150-day is not above the 200-day
- 2. 200-day trending up: fail. 200-day average A$0.34 vs A$0.34 a month ago (-0.8%): not rising
- 3. Well off the low: pass. Close A$0.41 is 102.5% above the 52-week low of A$0.20
- 4. Near the high: pass. 17.3% below the 52-week high
- 5. Relative strength: pass. 6-month relative strength +24.6 points, in the top quartile (cut-off +7.8)
- 6. Above the 50-day: pass. Close A$0.41 vs 50-day average A$0.32 (+26.2%)
- 7. Liquid enough to trade: fail. A$83k average daily turnover over 20 sessions, below the A$250k floor
Crowded-Short Breakout
WatchScore 15rank 638 of 1611
- 1. Crowded short: fail. 0.00% of shares on issue reported short, under 5%
- 2. Days to cover: fail. 0.0 days of average volume to cover, under 5
- 3. Breakout on heavy volume: fail. No close above the A$0.45 pivot on 1.5x volume in the last 5 sessions; close is -9.0% from the pivot
- 4. Market direction: fail. XJO in a downtrend: below its 200-day average
- 5. Liquid enough to trade: fail. A$83k average daily turnover over 20 sessions, below the A$250k floor
- 6. Relative strength: pass. Beat the S&P/ASX 200 by 66.3 points over 3 months
Quality compounders
WatchScore 35rank 19 of 1171
- 1. High return on equity: unknown. Return on equity cannot be measured: it needs net profit, equity at both ends of the year and, outside banks, insurers and other financials, equity of at least 10% of total assets
- 2. Healthy profit margin: pass. Net margin 15.1% (12 months to 2026-06-30)
- 3. Profit that turns into cash: fail. Free cash flow is 0.32x net profit (12 months to 2026-06-30), under 0.8x
- 4. Little debt: unknown. Net debt cannot be measured: no aligned balance sheet with debt and cash
- 5. Liquid enough to trade: fail. A$83k average daily turnover over 20 sessions, below the A$250k floor
- 6. Long-term uptrend: pass. Close A$0.41 vs 200-day average A$0.34 (+18.7%)
- 7. Revenue not shrinking: pass. Revenue +79.8% YoY (FY ending 2024-06-30), accelerating from +75.9%